GlassScriptPhysician profile
Ernesto S Duterte
NPI 1851488324
$3,659.43
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,704 · 2020: $280 · 2022: $1,675.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,675.00 | 2022 | |
| Amgen INC. | $515.11 | 2019-2020 | |
| Astellas Pharma US INC | $313.28 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $286.47 | 2019 | |
| Novo Nordisk INC | $285.29 | 2019-2020 | |
| Lilly USA, LLC | $132.79 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $97.67 | 2019 | |
| Allergan, INC. | $95.05 | 2020 | |
| Glaxosmithkline, LLC. | $68.42 | 2019 | |
| Medtronic Vascular, INC. | $54.77 | 2019 | |
| Shire North American Group INC | $38.13 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.26 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $28.01 | 2019 | |
| Sanofi Pasteur INC. | $14.70 | 2019 | |
| Arbor Pharmaceuticals, INC. | $14.38 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Circassia INC. | $12.10 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ernesto Duterte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.